Cargando…

Ramulus Mori (Sangzhi) Alkaloids (SZ-A) Ameliorate Glucose Metabolism Accompanied by the Modulation of Gut Microbiota and Ileal Inflammatory Damage in Type 2 Diabetic KKAy Mice

The novel Traditional Chinese Medicine Ramulus Mori (Sangzhi) alkaloid tablets (SZ-A) are approved by The China National Medical Products Administration for the treatment of type 2 diabetes mellitus (T2DM). However, the extensive pharmacological characteristics and the underlying mechanism are unkno...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Quan, Liu, Shuainan, Cao, Hui, Ji, Wenming, Li, Caina, Huan, Yi, Lei, Lei, Fu, Yaxin, Gao, Xuefeng, Liu, Yuling, Shen, Zhufang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082153/
https://www.ncbi.nlm.nih.gov/pubmed/33935735
http://dx.doi.org/10.3389/fphar.2021.642400
_version_ 1783685791530090496
author Liu, Quan
Liu, Shuainan
Cao, Hui
Ji, Wenming
Li, Caina
Huan, Yi
Lei, Lei
Fu, Yaxin
Gao, Xuefeng
Liu, Yuling
Shen, Zhufang
author_facet Liu, Quan
Liu, Shuainan
Cao, Hui
Ji, Wenming
Li, Caina
Huan, Yi
Lei, Lei
Fu, Yaxin
Gao, Xuefeng
Liu, Yuling
Shen, Zhufang
author_sort Liu, Quan
collection PubMed
description The novel Traditional Chinese Medicine Ramulus Mori (Sangzhi) alkaloid tablets (SZ-A) are approved by The China National Medical Products Administration for the treatment of type 2 diabetes mellitus (T2DM). However, the extensive pharmacological characteristics and the underlying mechanism are unknown. This study investigated the mechanisms by which SZ-A ameliorates glucose metabolism in KKAy mice, an animal model of T2DM. Diabetic KKAy mice were treated intragastrically with SZ-A once daily for 8 weeks, after which glucose levels, lipid metabolism, gut microbiome, systemic inflammatory factors, luminal concentrations of short-chain fatty acids (fecal samples), and ileal proteomic changes were evaluated. The ileum tissues were collected, and the effects of SZ-A on pathological inflammatory damage were evaluated by hematoxylin and eosin staining, immunofluorescence, and immunohistochemistry. The mRNA and protein expression levels of various inflammatory markers, including monocyte chemoattractant protein-1 and phosphorylated nuclear factor kappa B p65, were detected in the ileum tissues. SZ-A improved glucose metabolism with enhanced insulin response and elevated glucagon-like peptide 1 (GLP-1) nearly 2.7-fold during the glucose tolerance test in diabetic KKAy mice. Gut microbiota analysis demonstrated that SZ-A administration elevated the abundance of Bacteroidaceae and Verrucomicrobia, reduced the levels of Rikenellaceae and Desulfovibrionaceae; and increased the concentrations of fecal acetic and propionic acids compared to the diabetic model group. Additionally, SZ-A markedly improved ileal inflammatory injury and pro-inflammatory macrophage infiltration and improved intestinal mucosal barrier function in diabetic KKAy mice. SZ-A also attenuated the levels of circulating endotoxin, pro-inflammatory cytokines, and chemokines in the mice sera. Collectively, SZ-A ameliorated the overall metabolic profile including glucose and lipid metabolism in KKAy mice, which may be associated with an improvement in GLP-1 and insulin secretion, at least in part by modulating the gut microbiome and relieving the degree of ileal and systemic inflammation.
format Online
Article
Text
id pubmed-8082153
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-80821532021-04-30 Ramulus Mori (Sangzhi) Alkaloids (SZ-A) Ameliorate Glucose Metabolism Accompanied by the Modulation of Gut Microbiota and Ileal Inflammatory Damage in Type 2 Diabetic KKAy Mice Liu, Quan Liu, Shuainan Cao, Hui Ji, Wenming Li, Caina Huan, Yi Lei, Lei Fu, Yaxin Gao, Xuefeng Liu, Yuling Shen, Zhufang Front Pharmacol Pharmacology The novel Traditional Chinese Medicine Ramulus Mori (Sangzhi) alkaloid tablets (SZ-A) are approved by The China National Medical Products Administration for the treatment of type 2 diabetes mellitus (T2DM). However, the extensive pharmacological characteristics and the underlying mechanism are unknown. This study investigated the mechanisms by which SZ-A ameliorates glucose metabolism in KKAy mice, an animal model of T2DM. Diabetic KKAy mice were treated intragastrically with SZ-A once daily for 8 weeks, after which glucose levels, lipid metabolism, gut microbiome, systemic inflammatory factors, luminal concentrations of short-chain fatty acids (fecal samples), and ileal proteomic changes were evaluated. The ileum tissues were collected, and the effects of SZ-A on pathological inflammatory damage were evaluated by hematoxylin and eosin staining, immunofluorescence, and immunohistochemistry. The mRNA and protein expression levels of various inflammatory markers, including monocyte chemoattractant protein-1 and phosphorylated nuclear factor kappa B p65, were detected in the ileum tissues. SZ-A improved glucose metabolism with enhanced insulin response and elevated glucagon-like peptide 1 (GLP-1) nearly 2.7-fold during the glucose tolerance test in diabetic KKAy mice. Gut microbiota analysis demonstrated that SZ-A administration elevated the abundance of Bacteroidaceae and Verrucomicrobia, reduced the levels of Rikenellaceae and Desulfovibrionaceae; and increased the concentrations of fecal acetic and propionic acids compared to the diabetic model group. Additionally, SZ-A markedly improved ileal inflammatory injury and pro-inflammatory macrophage infiltration and improved intestinal mucosal barrier function in diabetic KKAy mice. SZ-A also attenuated the levels of circulating endotoxin, pro-inflammatory cytokines, and chemokines in the mice sera. Collectively, SZ-A ameliorated the overall metabolic profile including glucose and lipid metabolism in KKAy mice, which may be associated with an improvement in GLP-1 and insulin secretion, at least in part by modulating the gut microbiome and relieving the degree of ileal and systemic inflammation. Frontiers Media S.A. 2021-04-15 /pmc/articles/PMC8082153/ /pubmed/33935735 http://dx.doi.org/10.3389/fphar.2021.642400 Text en Copyright © 2021 Liu, Liu, Cao, Ji, Li, Huan, Lei, Fu, Gao, Liu and Shen. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Liu, Quan
Liu, Shuainan
Cao, Hui
Ji, Wenming
Li, Caina
Huan, Yi
Lei, Lei
Fu, Yaxin
Gao, Xuefeng
Liu, Yuling
Shen, Zhufang
Ramulus Mori (Sangzhi) Alkaloids (SZ-A) Ameliorate Glucose Metabolism Accompanied by the Modulation of Gut Microbiota and Ileal Inflammatory Damage in Type 2 Diabetic KKAy Mice
title Ramulus Mori (Sangzhi) Alkaloids (SZ-A) Ameliorate Glucose Metabolism Accompanied by the Modulation of Gut Microbiota and Ileal Inflammatory Damage in Type 2 Diabetic KKAy Mice
title_full Ramulus Mori (Sangzhi) Alkaloids (SZ-A) Ameliorate Glucose Metabolism Accompanied by the Modulation of Gut Microbiota and Ileal Inflammatory Damage in Type 2 Diabetic KKAy Mice
title_fullStr Ramulus Mori (Sangzhi) Alkaloids (SZ-A) Ameliorate Glucose Metabolism Accompanied by the Modulation of Gut Microbiota and Ileal Inflammatory Damage in Type 2 Diabetic KKAy Mice
title_full_unstemmed Ramulus Mori (Sangzhi) Alkaloids (SZ-A) Ameliorate Glucose Metabolism Accompanied by the Modulation of Gut Microbiota and Ileal Inflammatory Damage in Type 2 Diabetic KKAy Mice
title_short Ramulus Mori (Sangzhi) Alkaloids (SZ-A) Ameliorate Glucose Metabolism Accompanied by the Modulation of Gut Microbiota and Ileal Inflammatory Damage in Type 2 Diabetic KKAy Mice
title_sort ramulus mori (sangzhi) alkaloids (sz-a) ameliorate glucose metabolism accompanied by the modulation of gut microbiota and ileal inflammatory damage in type 2 diabetic kkay mice
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082153/
https://www.ncbi.nlm.nih.gov/pubmed/33935735
http://dx.doi.org/10.3389/fphar.2021.642400
work_keys_str_mv AT liuquan ramulusmorisangzhialkaloidsszaameliorateglucosemetabolismaccompaniedbythemodulationofgutmicrobiotaandilealinflammatorydamageintype2diabetickkaymice
AT liushuainan ramulusmorisangzhialkaloidsszaameliorateglucosemetabolismaccompaniedbythemodulationofgutmicrobiotaandilealinflammatorydamageintype2diabetickkaymice
AT caohui ramulusmorisangzhialkaloidsszaameliorateglucosemetabolismaccompaniedbythemodulationofgutmicrobiotaandilealinflammatorydamageintype2diabetickkaymice
AT jiwenming ramulusmorisangzhialkaloidsszaameliorateglucosemetabolismaccompaniedbythemodulationofgutmicrobiotaandilealinflammatorydamageintype2diabetickkaymice
AT licaina ramulusmorisangzhialkaloidsszaameliorateglucosemetabolismaccompaniedbythemodulationofgutmicrobiotaandilealinflammatorydamageintype2diabetickkaymice
AT huanyi ramulusmorisangzhialkaloidsszaameliorateglucosemetabolismaccompaniedbythemodulationofgutmicrobiotaandilealinflammatorydamageintype2diabetickkaymice
AT leilei ramulusmorisangzhialkaloidsszaameliorateglucosemetabolismaccompaniedbythemodulationofgutmicrobiotaandilealinflammatorydamageintype2diabetickkaymice
AT fuyaxin ramulusmorisangzhialkaloidsszaameliorateglucosemetabolismaccompaniedbythemodulationofgutmicrobiotaandilealinflammatorydamageintype2diabetickkaymice
AT gaoxuefeng ramulusmorisangzhialkaloidsszaameliorateglucosemetabolismaccompaniedbythemodulationofgutmicrobiotaandilealinflammatorydamageintype2diabetickkaymice
AT liuyuling ramulusmorisangzhialkaloidsszaameliorateglucosemetabolismaccompaniedbythemodulationofgutmicrobiotaandilealinflammatorydamageintype2diabetickkaymice
AT shenzhufang ramulusmorisangzhialkaloidsszaameliorateglucosemetabolismaccompaniedbythemodulationofgutmicrobiotaandilealinflammatorydamageintype2diabetickkaymice